25/11/2020

EuropaBio Statement on the EU Pharmaceutical Strategy

EuropaBio looks forward to working closely with the European institutions to ensure the Pharmaceutical Strategy delivers for European patients and establishes a framework that enables a successful life sciences sector for the medium to long-term.
30/04/2020

How soon can we respond to COVID-19?

The development of a vaccine or an antiviral treatment is a long and complex process. So why are we hearing that a vaccine against COVID-19 may be ready in a year from now, or even sooner?
30/04/2020

CRISPR and Coronavirus

A recent interview with Prof. Jennifer Doudna, a co-discoverer of the CRISPR-Cas9 system for genome editing, highlights potential applications of the technology to COVID-19.
30/04/2020

World Haemophilia Day – Interview with Amanda Bok (EHC)

The 30th anniversary of World Haemophilia Day helps to illustrate the importance to support the bleeding disorders community. Read our interview with Amanda Bok, CEO of the European Haemophilia Consortium (EHC) & Co-Chair of EuropaBio's Patients BioForum.